Related Experiment Videos
[Pathogenesis and therapy of rheumatoid inflammation]
Immunitat Und Infektion
|May 1, 1986
Summary
Rheumatoid arthritis patients show increased monocyte proliferation in bone marrow, linked to inflammation markers. Targeting monocytes/macrophages may offer new therapeutic strategies for rheumatoid arthritis.
Area of Science:
- Immunology
- Pathophysiology
- Pharmacology
Context:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
- The mononuclear phagocyte (MNP) system, including monocytes and macrophages, plays a crucial role in RA pathogenesis.
Purpose:
- To investigate the role of monocyte proliferation in rheumatoid arthritis.
- To explore the therapeutic potential of targeting the MNP system in RA.
Summary:
- Enhanced 3H-thymidine labeling demonstrated increased monocyte proliferation in the bone marrow of RA patients.
- This proliferation positively correlated with erythrocyte sedimentation rate and negatively with age.
- Benoxaprofen, a lipoxygenase inhibitor, suppressed experimental allergic synovitis, highlighting MNP system involvement.
Impact:
- Findings underscore the critical role of the MNP system in RA pathogenesis.
- Monocytes/macrophages represent a significant target cell system for developing novel antirheumatic drugs.